First, the results in Fig 2 exhibit that the expression level of FUNDC2 is significantly associated with the survival and prognosis of patients with diverse cancers, indicating that FUNDC2 may serve as a prognostic biomarker of cancer patients. Here, FUNDC2 is linked to cancer.